A de novo 2q37.2 deletion encompassing AGAP1 and SH3BP4 in a patient with autism and intellectual disability

Eur J Med Genet. 2019 Dec;62(12):103586. doi: 10.1016/j.ejmg.2018.11.020. Epub 2018 Nov 22.

Abstract

Autism spectrum disorders are complex neurodevelopmental syndromes characterized by phenotypic and genetic heterogeneity. Further identification of causal genes may help in better understanding the underlying mechanisms of the disorder, thus improving the patients' management. To date, abnormal synaptogenesis is thought to be one of the major underlying causes of autism spectrum disorders. Here, using oligoarray-based comparative genomic hybridization, we identified a de novo deletion at 2q37.2 locus spanning 1 Mb and encompassing AGAP1 and SH3BP4, in a boy with autism and intellectual disability. Both genes have been described as being involved in endosomal trafficking, and AGAP1 in particular has been shown to be expressed in the developing brain and to play a role in dendritic spine formation and synapse function, making it a potential causative gene to our patient's phenotype.

Keywords: AGAP1; Array CGH; Autism spectrum disorder; Intellectual disability; SH3BP4.

Publication types

  • Case Reports

MeSH terms

  • Adaptor Proteins, Signal Transducing / genetics
  • Autistic Disorder / genetics*
  • Autistic Disorder / pathology
  • Child
  • Chromosome Deletion
  • Chromosomes, Human, Pair 2 / genetics
  • GTPase-Activating Proteins / genetics
  • Humans
  • Intellectual Disability / genetics*
  • Intellectual Disability / pathology
  • Male

Substances

  • AGAP1 protein, human
  • Adaptor Proteins, Signal Transducing
  • GTPase-Activating Proteins
  • SH3BP4 protein, human

Supplementary concepts

  • Chromosome 2q37 deletion syndrome